Related content

Immunogenicity and reactogenicity of a single dose of a diphtheria-tetanus-acellular pertussis component vaccine (DTaP) compared to a diphtheria-tetanus toxoid (Td) and a diphtheria toxoid vaccine (d) in adults

By Bartels I.   Jungert J.   Lugauer S.   Stehr K.   Heininger U.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3137-3145

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine administered according to two different primary vaccination schedules

By Multicenter Working Group   Giammanco G.   Moiraghi A.   Zotti C.   Pignato S.   Li Volti S.   Giammanco A.   Soncini R.  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 722-726

Elsevier

Access to resources Recommend Favorite

A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults

By Van der Wielen M.   Van Damme P.   Joossens E.   Francois G.   Meurice F.   Ramalho A.  

Vaccine, Vol. 18, Iss. 20, 2000-04 ,pp. : 2075-2082

Elsevier

Access to resources Recommend Favorite

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults

By Halperin S.A.   Smith B.   Russell M.   Hasselback P.   Guasparini R.   Skowronski D.   Meekison W.   Parker R.   Lavigne P.   Barreto L.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1312-1319

Elsevier

Access to resources Recommend Favorite

Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age

By Dagan R.   Igbaria K.   Piglansky L.   Van Brusteghem F.   Melot V.   Kaufhold A.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2620-2627

Elsevier

Access to resources Recommend Favorite